Published: 2018-12-08

Articles

PHARMACEUTICAL EXPENDITURE COMPARED ACROSS COUNTRIES

C. van Mosseveld
Abstract 132 | PDF Downloads 89

TOXIC EPIDERMAL NECROLYSIS AND CLARITHROMYCIN

Nadia Khaldi, Alain Miras, Sophie Gromb
Abstract 111 | PDF Downloads 122

COMPLIANCE ASSESSMENT IN DRUG TRIALS: HAS THERE BEEN IMPROVEMENT IN TWO DECADES?

Shiva Jayaraman, Michael J Rieder, Doreen M Matsui
Abstract 115 | PDF Downloads 115

CARDIOVASCULAR COLLAPSE FROM LOW DOSE BUPIVACAINE

Marc E Levsky, Michael A Miller
Abstract 685 | PDF Downloads 294

ARE BRAND-NAME AND GENERIC WARFARIN INTERCHANGEABLE? A SURVEY OF ONTARIO PATIENTS AND PHYSICIANS

Jennifer A Pereira, Anne M Holbrook, Lisa Dolovich Dolovich, Charles Goldsmith, , Lehana Thabane, James D Douketis, Mark Crowther, Shannon M Bates, Jeffrey S Ginsberg
Abstract 210 | PDF Downloads 129

THE ROLE OF BUSPIRONE FOR THE TREATMENT OF CEREBELLAR ATAXIA IN AN OLDER INDIVIDUAL

Jayna M Holroyd-Leduc, Barbara A Liu, Brian E Mak I, Aleksandra Zecevic, Nathan Herrmann, Sandra E Black
Abstract 322 | PDF Downloads 68

CLINICAL TRIAL APPLICATIONS IN CANADA

Agnes V Klein, Anne M Tomalin
Abstract 193 | PDF Downloads 330